ArticleMaterials (Basel, Switzerland)2021
Surface Finishing of Additive Manufactured Ti-6Al-4V Alloy: A Comparison between Abrasive Fluidized Bed and Laser Finishing.
Article in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Application of Laser and Cryogenic Surface Treatment for the Evolution of Surface Morphology in Additively Manufactured Ti-6Al-4V Alloy Samples.Materials (Basel, Switzerland) · 2025Article
- An Electrochemical Study of the Corrosion Behaviour of the Polished Atomic Diffusion Additive Manufactured 17-4PH Stainless Steel Using Centrifugal Mass Finishing Method in Saltwater.Materials (Basel, Switzerland) · 2025Article
- Hydrojet Surface Treatment of Ti-6Al-4V Titanium Produced by Additive Manufacturing.Materials (Basel, Switzerland) · 2025Article
- An Overview of the Latest Progress in Internal Surface Finishing of the Additively Manufactured Metallic Components.Materials (Basel, Switzerland) · 2023Review
- Energy consumption assessment in manufacturing Ti6Al4V electron beam melted parts post-processed by machining.The International journal, advanced manufacturing technology · 2023Article
- Electron beam surface remelting enhanced corrosion resistance of additively manufactured Ti-6Al-4V as a potential in-situ re-finishing technique.Scientific reports · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metal additive manufacturing is a major concern for advanced manufacturing industries thanks to its ability to manufacture complex-shaped parts in materials that are difficult to machine using conventional methods. Nowadays, it is increasingly being used in the industrial manufacturing of titanium-alloy components for aerospace and medical industries; however, the main weakness of structural parts is the fatigue life, which is affected by surface quality, meaning the micro-cracking of small surface defects induced by the manufacturing process. Laser finishing and Abrasive Fluidized Bed are proposed by the authors since they represent cost-effective and environment-friendly alternatives for automated surface finishing. A comparison between these two finishing technologies was established and discussed. Experimental tests investigated both mechanical properties and fatigue performances. The tests also focused on understanding the basic mechanisms involved in fatigue failures of machined Ti-6Al-4V components fabricated via Electron Beam Melting and the effects of operational parameters. X-ray tomography was used to evaluate the internal porosity to better explain the fatigue behaviour. The results demonstrated the capability of Laser finishing and Abrasive Fluidized Beds to improve failure performances. Life Cycle Analysis was additionally performed to verify the effectiveness of the proposed technologies in terms of environmental impact and resource consumption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.